Development of a Non‐Coding‐RNA‐based EMT/CSC Inhibitory Nanomedicine for In Vivo Treatment and Monitoring of HCC

Advanced Science

  ^{1    1    2    2    2    3    4    4    5    5} 

[1] Department of General Surgery, The First Affiliated Hospital of Sun Yat‐Sen University, Guangzhou, 510080, China;Department of General Surgery, The First Affiliated Hospital of Sun Yat‐Sen University, Guangzhou, 510080, China;Department of Obstetrics and Gynecology and Medical Ultrasonics, The First Affiliated Hospital of Sun Yat‐Sen University, Guangzhou, 510080, China;Department of General Surgery, The First Affiliated Hospital of Sun Yat‐Sen University, Guangzhou, 510080, China;Department of Radiation Oncology, Tianjin Medical University Cancer Institute & Hospital, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Tianjin, 300060, China;Department of General Surgery, The First Affiliated Hospital of Sun Yat‐Sen University, Guangzhou, 510080, China;Department of Radiology and VIP Medical Center, The Third Affiliated Hospital of Sun Yat‐Sen University, Guangzhou, 510630, China;Department of General Surgery, The First Affiliated Hospital of Sun Yat‐Sen University, Guangzhou, 510080, China;School of Biomedical Engineering, Sun Yat‐Sen University, Guangzhou, 510006, China;

关键词: cancer stem cells;    epithelial–mesenchymal transition;    hepatocellular carcinoma;    microRNA‐125b‐5p;    nanocarriers;   

DOI  :  10.1002/advs.201801885

来源: publisher

【 授权许可】

Unknown